Xenetic

$2.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.25 (-9.33%) Today

+$0.27 (+11.11%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Xenetic and other stocks, options, and ETFs commission-free!

About XBIO

Xenetic Biosciences, Inc. engages in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA. The listed name for XBIO is Xenetic Biosciences, Inc. Common Stock.

CEO

Jeffrey F. Eisenberg

Employees

Headquarters

Framingham, Massachusetts

Founded

2011

Market Cap

19.62M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

857.13K

High Today

$2.67

Low Today

$2.42

Open Price

$2.62

Volume

367.70K

52 Week High

$5.85

52 Week Low

$0.44

Collections

XBIO Earnings

-$1.56

-$1.04

-$0.52

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 26, Pre-Market